Anagrelide HCl 1 mg Oral Capsule
RxNorm 597852
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 597852 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: anagrelide HCl 1 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Anagrelide 1 mg Oral Capsule
(Atom ID: 2360185)
PTPrescribable
Designated preferred name (PT):
Anagrelide (as anagrelide hydrochloride) 1 mg oral capsule
(Atom ID: 12664620)
SYPrescribable
Synonym (SY):
Anagrelide 1 mg (as anagrelide HCl) Oral Capsule
(Atom ID: 9198044)
PSNPrescribable
Prescribable Name (PSN):
Anagrelide HCl 1 mg Oral Capsule
(Atom ID: 7739178)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely anagrelide (as anagrelide hydrochloride) 1 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 12665746)
Patient Education
Anagrelide
Anagrelide is used to decrease the number of platelets (a type of blood cell that is needed to control bleeding) in the blood of patients who have a bone marrow disorder, in which the body makes too many of one or more types of blood cells, such as essential thrombocythemia (condition in which the body makes too many platelets) or polycythemia vera (condition in which the body makes too many red blood cells and sometimes too many platelets). Anagrelide is in a class of medications called platelet-reducing agents. It works by slowing the production of platelets in the body.
[Learn More]
* Please review the disclaimer below.